top of page
Xatmep is an oral treatment for the cancer Acute Lymphoblastic Leukemia (ALL) and certain types of juvenile arthritis. Fact Table Formula C20H22N8O5 License US FDA, EU EMA Bioavailability 60% at lower doses, less at higher doses Legal status Rx-Only Chemical Name Methotrexate Elimination half-life 3–10 hours (lower doses), 8–15 hours (higher doses) Dosage (Strength) 2.25mg Pregnancy Not Advised Brands Trexall, Rheumatrex, Otrexup Protein binding 35–50% (parent drug), 91–93% (7-hydroxymethotrexate) PubChem CID 126941 MedlinePlus a682019 ChEBI 44185 ATC code L01BA01 DrugBank DB00563 KEGG D00142 Routes of administration By mouth, intravenous (IV), intramuscular (IM), subcutaneous injection (SC), intrathecal

Xatmep (Methotrexate)

  • Take Xatmep as prescribed by your doctor. Each person will have a unique dose that is adjusted for them.
bottom of page